establishing safety and care requirements for clinician-administered drugs.

Summary

The bill defines clinician‑administered drugs and bars health insurers or pharmacy benefit managers from requiring ‘white‑bagging’ or ‘brown‑bagging’ unless written agreements and consent are obtained. It also stops them from limiting coverage, raising costs, or penalizing providers who use non‑network pharmacies. The aim is to keep drug administration safe and preserve patient and provider choice.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share